TY - CHAP M1 - Book, Section TI - Lung Volume Reduction Surgery A1 - van Berkel, Victor A1 - Meyers, Bryan F. A2 - Sugarbaker, David J. A2 - Bueno, Raphael A2 - Burt, Bryan M. A2 - Groth, Shawn S. A2 - Loor, Gabriel A2 - Wolf, Andrea S. A2 - Williams, Marcia A2 - Adams, Ann PY - 2020 T2 - Sugarbaker’s Adult Chest Surgery, 3e AB - Lung volume reduction surgery (LVRS) is one of the most interesting and controversial areas in thoracic surgery. The purpose of the operation is to palliate dyspnea and improve functional status and quality of life for highly selected patients with emphysema. Chronic obstructive pulmonary disease (COPD) affects approximately 16 million Americans and is the fourth leading cause of death in the United States.1 Worldwide there are estimated to be 1 billion smokers, and owing to a global increase in the number of smokers each year, COPD is projected to be the third leading cause of death by the year 2020.2 When pulmonary function tests demonstrate a forced expiratory volume in 1 second (FEV1) of less than 30% of predicted values, a patient’s 3-year mortality risk has been estimated at 40–50%. Although medical therapy remains the mainstay of treatment for these patients,3 no medical therapy is able to improve pulmonary function or reverse the progressive nature of the disease. Three situations have emerged in which surgery is useful to palliate emphysema: lung transplantation, bullectomy, and LVRS. This chapter addresses the LVRS strategy. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/10/14 UR - accesssurgery.mhmedical.com/content.aspx?aid=1170412721 ER -